Mrs Melinda Jo Hulett, APRN | |
1000 E Matthews Ave Ste E, Jonesboro, AR 72401-4344 | |
(870) 336-0472 | |
(870) 336-5321 |
Full Name | Mrs Melinda Jo Hulett |
---|---|
Gender | Female |
Speciality | Clinical Nurse Specialist - Adult Health |
Location | 1000 E Matthews Ave Ste E, Jonesboro, Arkansas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235172156 | NPI | - | NPPES |
177768758 | Medicaid | AR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
364SA2200X | Clinical Nurse Specialist - Adult Health | S01118 (Arkansas) | Primary |
Entity Name | Arkansas Department Of Health Payroll Office |
---|---|
Entity Type | Part B Supplier - Public Health/welfare Agency |
Entity Identifiers | NPI Number: 1619195906 PECOS PAC ID: 5799696779 Enrollment ID: O20090801000049 |
News Archive
For detecting cancer, manual breast exams seem low-tech compared to other methods such as MRI. But scientists are now developing an "electronic skin" that "feels" and images small lumps that fingers can miss.
In a landmark discovery, researchers at Tel Aviv University have unraveled the metastatic mechanism of melanoma, the most aggressive of all skin cancers.
More than one third of Americans are considered obese and approximately 15 million (5%) Americans now have a body mass index greater than 40. The April issue of the Journal of the American Dietetic Association focuses on the ever-increasing use of bariatric surgery to control the excess morbidity and mortality associated with extreme obesity and the important role that registered dietitians play in the management of patients who have undergone the procedure.
Bristol-Myers Squibb Company is pleased to announce that today the National Institute of Health and Clinical Excellence (NICE) has decided to recommend YERVOY (ipilimumab), which is approved in the European Union for the treatment of previously-treated metastatic (advanced) melanoma, within the Final Appraisal Determination (FAD).
Researchers from the Broad Institute and MIT have teamed up with colleagues from the University of Tokyo to form the first high definition picture of the Cas9 complex - a key part of the CRISPR-Cas system used by scientists as a genome-editing tool to silence genes and probe the biology of cells. Their findings, which are reported this week in Cell, are expected to help researchers refine and further engineer the tool to accelerate genomic research and bring the technology closer to use in the treatment of human genetic disease.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Melinda Jo Hulett, APRN 1000 E Matthews Ave Ste E, Jonesboro, AR 72401-4344 Ph: (870) 336-0472 | Mrs Melinda Jo Hulett, APRN 1000 E Matthews Ave Ste E, Jonesboro, AR 72401-4344 Ph: (870) 336-0472 |
News Archive
For detecting cancer, manual breast exams seem low-tech compared to other methods such as MRI. But scientists are now developing an "electronic skin" that "feels" and images small lumps that fingers can miss.
In a landmark discovery, researchers at Tel Aviv University have unraveled the metastatic mechanism of melanoma, the most aggressive of all skin cancers.
More than one third of Americans are considered obese and approximately 15 million (5%) Americans now have a body mass index greater than 40. The April issue of the Journal of the American Dietetic Association focuses on the ever-increasing use of bariatric surgery to control the excess morbidity and mortality associated with extreme obesity and the important role that registered dietitians play in the management of patients who have undergone the procedure.
Bristol-Myers Squibb Company is pleased to announce that today the National Institute of Health and Clinical Excellence (NICE) has decided to recommend YERVOY (ipilimumab), which is approved in the European Union for the treatment of previously-treated metastatic (advanced) melanoma, within the Final Appraisal Determination (FAD).
Researchers from the Broad Institute and MIT have teamed up with colleagues from the University of Tokyo to form the first high definition picture of the Cas9 complex - a key part of the CRISPR-Cas system used by scientists as a genome-editing tool to silence genes and probe the biology of cells. Their findings, which are reported this week in Cell, are expected to help researchers refine and further engineer the tool to accelerate genomic research and bring the technology closer to use in the treatment of human genetic disease.
› Verified 1 days ago
Mrs. Jennifer Sifford, APN Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 300 Carson St, Jonesboro, AR 72401 Phone: 870-932-1198 | |
Stephanie Mcmellon, APRN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 201 E Oak Ave, Jonesboro, AR 72401 Phone: 870-935-6729 Fax: 870-268-4410 | |
Savanna Hailey, APRN Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 1021 Neil Dr, Jonesboro, AR 72401 Phone: 870-898-0088 | |
Jennifer M Lewis, APRN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 201 E Oak Ave, Jonesboro, AR 72401 Phone: 870-935-6729 | |
Carie Wells, APRN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 4802 E Johnson Ave, Jonesboro, AR 72401 Phone: 870-936-8000 Fax: 870-934-3635 | |
Madison Birdno, Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 303 E Matthews Ave Ste 202, Jonesboro, AR 72401 Phone: 870-207-7566 | |
Barbara Frances Gray, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2020 Hytrol St, Jonesboro, AR 72401 Phone: 870-972-8953 |